Target intelligence / Profile preview

Acellular scaffold (AS)

Target
AS
Molecular classification
Extracellular matrix, Structural protein complex, Biomaterial, Other
01

Overview

An acellular scaffold is a complex biological structure produced by removing all cellular components from a donor tissue or organ while preserving the native extracellular matrix (ECM) [1: Crapo et al., 2011, Biomaterials]. This decellularization process retains the essential structural proteins, such as collagen and elastin, and biochemical cues like glycosaminoglycans that are critical for cell-matrix interactions [2: Gilbert et al., 2006, Biomaterials]. In clinical applications, these scaffolds serve as a template for regenerative medicine, promoting the infiltration of host cells and the subsequent remodeling of the scaffold into functional tissue [3: Badylak, 2004, Seminars in Cell & Developmental Biology]. They are widely utilized in wound healing, cardiovascular repair, and reconstructive surgery due to their ability to mimic the natural microenvironment better than synthetic alternatives [4: Ott et al., 2008, Nature Medicine]. While highly effective, the success of acellular scaffolds depends on the thoroughness of cell removal to prevent adverse immune reactions and the maintenance of structural integrity to support mechanical loads [5: Keane et al., 2015, Methods].

Other names
Decellularized extracellular matrixdECMAcellular matrixBiological scaffoldBiomatrix
02

Mechanism of action

Acellular scaffolds function by providing a three-dimensional structural and biochemical template that mimics the native extracellular matrix, thereby facilitating host cell recruitment, adhesion, proliferation, and differentiation for tissue regeneration [1, 2, 3].

03

Biological functions

Structural supportCell adhesionCell signalingTissue remodelingAngiogenesisCell proliferationOther
04

Disease associations

Chronic woundsOrgan failureHerniaCardiovascular diseaseSoft tissue defectOther
05

Safety considerations

Immunogenic response to residual cellular debrisRisk of zoonotic disease transmission (xenografts)Mechanical degradation or failureCalcificationIncomplete decellularization
06

Interacting drugs

Vascular endothelial growth factor (VEGF)

4 more in the full profile.

07

Biomarkers

Residual DNA content (<50 ng/mg)DNA fragment length (<200 bp)Collagen concentrationGlycosaminoglycan (GAG) content

Beyond the preview

Go deeper on Acellular scaffold (AS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acellular scaffold (AS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call